Genetic testing for hereditary breast and ovarian cancer revealed two pathogenic variants in the <i>BRCA1</i> (c.5095C>T, p.(Arg1699Trp)) and in <i>BRCA2</i> genes (c.658_659delGT, p.(Val220Ilefs*4)) in heterozygous form. Here, BRCA2 is linked to ovarian cancer.